DABIGATRAN ÉTEXILATE (MÉSILATE DE)

Published records containing this source ingredient. These medicines are not necessarily interchangeable.

9 records from the French BDPM composition tables. Source ingredient identifiers are preserved; source names can differ across formulations. Clinical ingredient guidance is not yet included.

France · CIS 60292648

DABIGATRAN ETEXILATE BIOGARAN 110 mg, gélule

gélule / BIOGARAN

France · CIS 68417210

DABIGATRAN ETEXILATE BIOGARAN 150 mg, gélule

gélule / BIOGARAN

France · CIS 68370173

DABIGATRAN ETEXILATE BIOGARAN 75 mg, gélule

gélule / BIOGARAN

France · CIS 66272549

DABIGATRAN ETEXILATE ZENTIVA K.S. 110 mg, gélule

gélule / ZENTIVA FRANCE

France · CIS 61511205

DABIGATRAN ETEXILATE ZENTIVA K.S. 150 mg, gélule

gélule / ZENTIVA FRANCE

France · CIS 68185986

DABIGATRAN ETEXILATE ZENTIVA K.S. 75 mg, gélule

gélule / ZENTIVA FRANCE

France · CIS 65570603

PRADAXA 110 mg, gélule

gélule / BOEHRINGER INGELHEIM INTERNATIONAL

France · CIS 63484283

PRADAXA 150 mg, gélule

gélule / BOEHRINGER INGELHEIM INTERNATIONAL

France · CIS 65693901

PRADAXA 75 mg, gélule

gélule / BOEHRINGER INGELHEIM INTERNATIONAL

Sources and review process →